Skip to main content
Journal cover image

Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.

Publication ,  Journal Article
Dang, Z; Lai, W; Qian, K; Ho, P; Lee, K-H; Chen, C-H; Huang, L
Published in: J Med Chem
December 10, 2009

We previously reported that [[N-[3beta-hydroxyllup-20(29)-en-28-oyl]-7-aminoheptyl]carbamoyl]methane (A43D, 4) was a potent HIV-1 entry inhibitor. However, 4 was inactive against HIV-2 virus, suggesting the structural requirements for targeting these two retroviruses are different. In this study, a series of new betulinic acid derivatives were synthesized, and some of them displayed selective anti-HIV-2 activity at nanomolar concentrations. In comparison to compounds with anti-HIV-1 activity, a shorter C-28 side chain is required for optimal anti-HIV-2 activity.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Med Chem

DOI

EISSN

1520-4804

Publication Date

December 10, 2009

Volume

52

Issue

23

Start / End Page

7887 / 7891

Location

United States

Related Subject Headings

  • Triterpenes
  • Pentacyclic Triterpenes
  • Medicinal & Biomolecular Chemistry
  • Inhibitory Concentration 50
  • Humans
  • HIV-2
  • HIV-1
  • Dose-Response Relationship, Drug
  • Cell Line
  • Betulinic Acid
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dang, Z., Lai, W., Qian, K., Ho, P., Lee, K.-H., Chen, C.-H., & Huang, L. (2009). Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. J Med Chem, 52(23), 7887–7891. https://doi.org/10.1021/jm9004253
Dang, Zhao, Weihong Lai, Keduo Qian, Phong Ho, Kuo-Hsiung Lee, Chin-Ho Chen, and Li Huang. “Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.J Med Chem 52, no. 23 (December 10, 2009): 7887–91. https://doi.org/10.1021/jm9004253.
Dang Z, Lai W, Qian K, Ho P, Lee K-H, Chen C-H, et al. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. J Med Chem. 2009 Dec 10;52(23):7887–91.
Dang, Zhao, et al. “Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.J Med Chem, vol. 52, no. 23, Dec. 2009, pp. 7887–91. Pubmed, doi:10.1021/jm9004253.
Dang Z, Lai W, Qian K, Ho P, Lee K-H, Chen C-H, Huang L. Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. J Med Chem. 2009 Dec 10;52(23):7887–7891.
Journal cover image

Published In

J Med Chem

DOI

EISSN

1520-4804

Publication Date

December 10, 2009

Volume

52

Issue

23

Start / End Page

7887 / 7891

Location

United States

Related Subject Headings

  • Triterpenes
  • Pentacyclic Triterpenes
  • Medicinal & Biomolecular Chemistry
  • Inhibitory Concentration 50
  • Humans
  • HIV-2
  • HIV-1
  • Dose-Response Relationship, Drug
  • Cell Line
  • Betulinic Acid